Placebo response: In studies on pain and under other clinical conditions;Placeboresponse: In Studien zum Schmerz und anderen klinischen Bedingungen

Schmerz

Volumn 25, Issue 3, 2011, Pages 325-335

  Weimer, K ^a   Horing, B ^a   Klosterhalfen, S ^a,b   Enck, P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Clinical trials; Depression; Irritable bowel syndrome; Pain; Placebo

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; COMPARATIVE STUDY; HUMAN; PAIN; PLACEBO EFFECT; REVIEW;

ANALGESICS; ANALGESICS, OPIOID; BRAIN; DEPRESSION; DRUG THERAPY, COMBINATION; DRUGS, INVESTIGATIONAL; HUMANS; IRRITABLE BOWEL SYNDROME; MAGNETIC RESONANCE IMAGING; PAIN; PAIN MEASUREMENT; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 79960365441     PISSN: 0932433X     EISSN: 14322129     Source Type: Journal    
DOI: 10.1007/s00482-010-1012-1     Document Type: Review

References (37)

1. Bridge JA, Birmaher B, Iyengar S et al (2009) Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 166(1):42-49
2. Castro M (2007) Placebo versus best-available-therapy control group in clinical trials for pharmacologic therapies: which is better? Proc Am Thorac Soc 4(7):570-573 (Pubitemid 47547853)
3. Colloca L, Lopiano L, Lanotte M, Benedetti F (2004) Overt versus covert treatment for pain, anxiety, and Parkinsons disease. Lancet Neurol 3:679-684 (Pubitemid 39370638)
4. Die MD van, Bone KM, Burger HG, Teede HJ (2009) Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial. BMC Med Res Methodol 9:41
5. Diener HC, Dowson AJ, Ferrari M et al (1999) Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia 19(8):699-700 (Pubitemid 29519411)
6. Ehni HJ, Wiesing U (2008) International ethical regulations on placebo-use in clinical trials: a comparative analysis. Bioethics 22:64-74 (Pubitemid 350264767)
7. Enck P, Benedetti F, Schedlowski M (2008) New insights into the placebo and nocebo responses. Neuron 59:195-206 (Pubitemid 352033692)
8. Enck P, Vinson B, Malfertheiner P et al (2009) Placebo effects in functional dyspepsia - reanalysis of trial data. Neurogastroenterol Motil 21(4):370-377
9. Enck P, Klosterhalfen S, Zipfel S (under revision) Study designs for experimental and clinical research on placebo analgesia and the placebo response. BMC Med Res Methodol under revision
10. Enck P, Junne F, Klosterhalfen S et al (2010) Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol 22:1402-1411
11. Evans KR, Sills T, Wunderlich GR, McDonald HP (2004) Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders? J Psychiatr Res 38(4):437-444 (Pubitemid 38760012)
12. Fässler M, Meissner K, Schneider A, Linde K (2010) Frequency and circumstances of placebo use in clinical practice - a systematic review of empirical studies. BMC Med 8:15
13. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F (2010) Biological, clinical, and ethical advances of placebo effects. Lancet 375(9715):686-695
14. Fiorillo CD, Tobler PN, Schultz W (2003) Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299:1898-1902 (Pubitemid 36356659)
15. Ford AC, Moayyedi P (2010) Meta-analysis: factors affecting placebo response rate in irritable bowel syndrome. Aliment Pharmacol Ther 32(2):144-158
16. Hegerl U, Mergl R (2010) The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences. J Psychopharmacol 24(4):445-448
17. Hill AB (1990) Suspended judgment: memories of the British streptomycin trial in tuberculosis. The first randomized clinical trial. Controlled Clin Trials 11:77-79
18. Ilnyckyj A, Shanahan F, Anton PA et al (1997) Quantification of the placebo response in ulcerative colitis. Gastroenterology 112(6):1854-1858 (Pubitemid 27240770)
19. Kirsch I (2000) Are drug and placebo effects in depression additive? Biol Psychiatry 47:733-735 (Pubitemid 30201669)
20. Kirsch I, Weixel LJ (1988) Double-blind versus deceptive administration of a placebo. Behav Neurosci 102:319-323
21. Kirsch I, Deacon BJ, Huedo-Medina TB et al (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PloS Med 5:e45
22. Klosterhalfen S, Vase L, Enck P (2010) The likelihood of receiving the drug determines the size of the placebo response. Neurogastroenterol Motil 22(S1):22
23. Lesaffre E (2008) Superiority, equivalence, and non-inferiority trials. Bull NYU Hosp Jt Dis 66(2):150-154. 35 (Pubitemid 351898384)
24. Miller FG, Wendler D, Swartzman LC (2005) Deception in research on the placebo effect. PloS Med 2:e262
25. Muthén B, Brown HC (2009) Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling. Stat Med 28(27):3363-3385
26. Niederau C, Bemba G, Kautz A et al (2010) Waiting time for and length of physicians consultation define the patient-physician interaction: results of a prospective study in 478 patients with chronic viral hepatitis. Z Gastroenterol 48(4):455-464
27. Papakostas GI, Fava M (2009) Does the probability of receiving place-bo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol 19(1):34-40
28. Patel SM, Stason WB, Legedza A et al (2005) The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 17:332-340 (Pubitemid 40768905)
29. Petrovic P, Kalso E, Petersson KM et al (2010) A prefrontal non-opioid mechanism in placebo analgesia. Pain 150(1):59-65
30. Puri KS, Suresh KR, Gogtay NJ, Thatte UM (2009) Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med 55:131-134
31. Rutherford BR, Sneed JR, Roose SP (2009) Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom 78(3):172-181
32. Scott DJ, Stohler CS, Egnatuk CM et al (2007) Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55:325-336 (Pubitemid 47048908)
33. Sinyor M, Levitt AJ, Cheung AH et al (2010) Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry 71:270-279
34. Talley NJ, Locke GR, Lahr BD et al (2006) Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther 23:923-936
35. Vase L, Riley JL, Price DD (2002) A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99:443-452 (Pubitemid 35284275)
36. Wager TD, Roy M (2010) Separate mechanisms for placebo and opiate analgesia? Pain 150(1):8-9
37. Welge JA, Keck PE Jr (2003) Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression. Psychopharmacology (Berl) 166:1-10 (Pubitemid 36286715)